Previous studies indicated both an angiostatic role [13] and an acute pro-inflammatory role [15] for the WARS1 protein, TrpRS, and therefore it may possess therapeutically relevant anti-cancer activities in certain cancer types. This evidence concerns the gene WARS2 and cancer.